Bedaquiline
Other Drugs For Treatment Of Tuberculosis
Sold as Sirturo
- Drug class
- Other Drugs For Treatment Of Tuberculosis
- Availability
- See label
- Markets covered
- 2
- Products on record
- 3
Overview
Bedaquiline is an active pharmaceutical ingredient in the Other Drugs For Treatment Of Tuberculosis group (J04AK). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | December 29, 2025 |
| EU European Union | EMA | 1 | November 24, 2025 |
GBUnited Kingdom· MHRA
2 products
Uses
SIRTURO is indicated for use as part of an appropriate combination regimen in adult and paediatric patients (2 years to less than 18 years of age and weighing at least 7 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampicin and isoniazid.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
How to take
EUEuropean Union· EMA
1 product
Uses
SIRTURO is indicated for use as part of an appropriate combination regimen in adult and paediatric patients (2 years to less than 18 years of age and weighing at least 7 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampicin and isoniazid.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
How to take
Drug interactions
Known interactions involving Bedaquiline. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 476. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PLGB002420744 · revised December 29, 2025
- [2]European Medicines Agency · EMEA/H/C/002614 · revised November 24, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.